Home/ Stocks/ ABSI

Absci Corporation Common Stock

ABSI XNAS

$5.90 +0.20 (+3.43%) ▲ 15-min delayed

Open

$5.04

High

$5.96

Low

$4.75

Volume

7.34M

Market Cap

$919.84M

About Absci Corporation Common Stock

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.

Sector: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH Employees: 140 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$215.0K	$-29,599,000	$-0.19
FY 2025	$2.80M	$-115,183,000	$-0.84
Q3 2025	$378.0K	$-28,706,000	$-0.20
Q2 2025	$593.0K	$-30,569,000	$-0.24

Related Market News

No specific coverage for ABSI yet. Check out our latest market news or earnings calendar.

Get ABSI Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Absci Corporation Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.